BCM
Bayesian Capital Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Sell |
98,200
-55,000
| -36% | -$1.33M | 0.38% | 71 |
|
|
2025
Q1 | $3.88M | Sell |
153,200
-28,400
| -16% | -$720K | 0.64% | 28 |
|
|
2024
Q4 | $4.82M | Buy |
181,600
+40,800
| +29% | +$1.08M | 0.59% | 28 |
|
|
2024
Q3 | $4.07M | Buy |
140,800
+85,700
| +156% | +$2.48M | 0.48% | 42 |
|
|
2024
Q2 | $1.54M | Sell |
55,100
-164,900
| -75% | -$4.61M | 0.18% | 155 |
|
|
2024
Q1 | $6.11M | Buy |
220,000
+44,800
| +26% | +$1.24M | 0.58% | 31 |
|
|
2023
Q4 | $5.04M | Buy |
175,200
+63,600
| +57% | +$1.83M | 0.54% | 33 |
|
|
2023
Q3 | $3.7M | Buy |
111,600
+51,300
| +85% | +$1.7M | 0.42% | 56 |
|
|
2023
Q2 | $2.21M | Buy |
60,300
+35,800
| +146% | +$1.31M | 0.24% | 108 |
|
|
2023
Q1 | $1,000K | Buy |
+24,500
| New | +$1,000K | 0.12% | 236 |
|
|
2022
Q3 | – | Sell |
-18,400
| Closed | -$965K | – | 949 |
|
|
2022
Q2 | $965K | Buy |
+18,400
| New | +$965K | 0.18% | 162 |
|
|
2022
Q1 | – | Sell |
-6,000
| Closed | -$354K | – | 887 |
|
|
2021
Q4 | $354K | Sell |
6,000
-28,900
| -83% | -$1.71M | 0.11% | 237 |
|
|
2021
Q3 | $1.5M | Sell |
34,900
-800
| -2% | -$34.4K | 0.43% | 56 |
|
|
2021
Q2 | $1.4M | Sell |
35,700
-60,644
| -63% | -$2.37M | 0.37% | 74 |
|
|
2021
Q1 | $3.49M | Buy |
96,344
+47,644
| +98% | +$1.73M | 0.8% | 20 |
|
|
2020
Q4 | $1.79M | Buy |
+48,700
| New | +$1.79M | 0.47% | 51 |
|
|
2020
Q2 | – | Sell |
-85,400
| Closed | -$2.79M | – | 720 |
|
|
2020
Q1 | $2.79M | Buy |
+85,400
| New | +$2.79M | 0.6% | 17 |
|
|
2016
Q3 | – | Sell |
-24,300
| Closed | -$856K | – | 464 |
|
|
2016
Q2 | $856K | Buy |
+24,300
| New | +$856K | 0.51% | 34 |
|